ChronoScale Corporation (CHRN) Stock Forecast and Price Target (2026)
Last updated November 2026
Short answer
There is no meaningful price-target consensus for ChronoScale Corporation (CHRN): too few analysts publish a target on it for an average to mean anything. Thin coverage is normal for smaller and newer companies and says nothing about the business. What does exist is an earnings forecast. For the fiscal year ending May 2027, the 2 analysts publishing estimates on CHRN expect earnings of -$0.49 per share and revenue of $138.7 million. The full quarter and fiscal-year estimates are below, with the drivers and risks that decide whether they are met. Walnut is not an investment adviser.
Why CHRN has no consensus price target
Sell-side coverage follows trading volume and banking relationships, so smaller companies, recent listings, and names outside the major indices often carry little or none. CHRN is one of them. It says nothing about the quality of the business, but it does mean there is no informed average to anchor to, and that any single target you find elsewhere is one analyst's model.
Figures are approximate and tied to the asOf date; verify live numbers before acting. At roughly 31 times trailing sales and with no earnings, ChronoScale is valued on the $1 billion run-rate revenue it says it has contracted for 2027 rather than on today's results. Analysts' estimates point the same way (about $132 million of revenue in the year to May 2027 and about $930 million the year after), which leaves the stock highly sensitive to any slip in deployments or financing.
CHRN earnings and revenue forecast
For the fiscal year ending May 2027, the 2 analysts publishing estimates on CHRN expect earnings of -$0.49 per share and revenue of $138.7 million.
| Period | EPS estimate | EPS growth | Revenue estimate | Revenue growth |
|---|---|---|---|---|
Quarter ending Nov 2026 next quarter to report, 2 analysts | -$0.13 -$0.19 to -$0.07 | n/a | $18.3 million $18.1 million to $18.5 million | n/a |
Quarter ending Feb 2027 the quarter after, 2 analysts | -$0.13 -$0.15 to -$0.10 | n/a | $25.6 million $18.5 million to $32.7 million | n/a |
Fiscal year ending May 2027 fiscal year next to report, 2 analysts | -$0.49 -$0.59 to -$0.39 | n/a | $138.7 million $132.3 million to $145 million | n/a |
Fiscal year ending May 2028 the fiscal year after, 2 analysts | $0.17 -$0.15 to $0.50 | n/a | $947.8 million $930.2 million to $965.3 million | +584% |
Consensus estimates for CHRN published by sell-side analysts, as of November 2026, from Yahoo Finance. Each figure is the average of the analysts counted, with the lowest and highest estimate beneath it; growth compares with the same period a year earlier and is left blank where either figure is a loss. Estimates change constantly. Walnut is not an investment adviser.
Estimates are the most widely published forecast there is: many more analysts model a company's earnings than publish a price target on it. They are also revised constantly, and the direction of those revisions into a report is often more informative than the level.
Is there a 2030 forecast for CHRN?
Not a published one. Analyst price targets run to about twelve months, occasionally two years, and the firms covering CHRN do not put out a 2030 number. Anything presenting one is extrapolating a growth rate of its own, and a figure produced that way tells you about the assumption chosen, not about the company.
What can be said over a long horizon is what the current price already assumes about the business, which is a question the filings answer and a forecast cannot.
For a ten-year question, that frame is more useful. A share price is the market’s estimate of future cash flows discounted to today, so the multiple is already a statement about growth. The long-horizon question is whether ChronoScale Corporation can deliver what is priced in, and what would have to change for that to break. Both are answerable from the drivers and risks below. A number for 2030 is not.
What could move CHRN from here
In short: the drivers cited most often are Riding AI compute demand, Independence and capital flexibility, Asset-backed, contract-driven model. The risk cited most often against it is the risks are substantial and stack together.
Both sides are worked through properly, with the high and low targets used as the bull and bear anchors, on the CHRN is it a buy page.
Your questions about ChronoScale Corporation
Ask Walnut's AI anything about CHRN and see how it fits what you own.
FAQ
What is the price target for ChronoScale Corporation (CHRN)?
+
There is no meaningful consensus price target for CHRN, because too few analysts publish on it. Thin coverage is common for smaller and newer companies. Where only one or two analysts cover a stock, an "average target" is really one person's model, so we do not print a number that would imply more agreement than exists. Check your broker's research tab for whatever individual coverage exists.
Is there an analyst forecast for CHRN?
+
For earnings, yes; for the share price, not a meaningful one. For the fiscal year ending May 2027, the 2 analysts publishing estimates on CHRN expect earnings of -$0.49 per share and revenue of $138.7 million. Fewer analysts publish a price target on CHRN than publish earnings estimates, which is common for smaller and newer companies, and a lack of target coverage says nothing about the business itself.
What are analysts' earnings estimates for ChronoScale Corporation (CHRN)?
+
For the fiscal year ending May 2027, the 2 analysts publishing estimates on CHRN expect earnings of -$0.49 per share and revenue of $138.7 million. For the fiscal year ending May 2028, the consensus is $0.17 per share. These are consensus estimates as of November 2026, the average of what the covering analysts publish, and they are revised constantly, especially around each earnings report. They describe expectations, not results.
What could move CHRN?
+
The drivers and the risks are laid out on this page and in more depth on the CHRN "is it a buy" page. Without analyst estimates to anchor to, the useful framing is a set of scenarios.
Walnut is informational, not investment advice, and does not publish price targets of its own. The analyst figures on this page come from a November 2026 data pull of published third-party research, are approximate, and change constantly. The share price is the last one Yahoo Finance reported on November 16, 2026, and every percentage against it on this page is measured from that price. Verify current figures with your broker before acting on them.